Updated:
Globus Medical
Globus Medical designs and manufactures musculoskeletal device solutions — its Excelsius robotic platform competes with Medtronic and Stryker.
Globus Medical
Globus Medical operates as a global musculoskeletal technology company headquartered in Audubon, Pennsylvania. The firm was founded in 2003 by former executives from Synthes and DePuy Spine aiming to bring rapid innovation to spine surgery. Its public ownership structure — NYSE ticker GMED — means its capital is deployed into product development rather than managed as a family office. The firm’s strategy spans three core areas: spinal implants and instruments, orthopedic trauma and joint reconstruction, and enabling technologies including the Excelsius robotics and navigation platform. Globus Medical’s product portfolio also includes regenerative biologics and power tools. The company manufactures in its own Pennsylvania facilities and maintains 19 additional offices from San Diego to Singapore. Confirmed surgical robotics competitors include Medtronic and Stryker (per GlobeNewswire, 2024). Globus Medical employs approximately 5,500 people globally (per its 2024 annual report). The Musculoskeletal Education and Research Center (MERC) in Audubon provides surgeon training through cadaveric labs and didactic sessions. In February 2024 the firm completed its acquisition of NuVasive for $3.1B (per SEC filing, February 2024), merging two spine-device manufacturers. What structurally distinguishes Globus Medical from other device makers is its internal rapid-prototyping model — product development teams use on-site fabrication and testing facilities to move from concept to validated product without external contract manufacturers. This vertical integration shortens development cycles and gives the firm direct control over supply chain and intellectual property.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Audubon
Corporate office
Audubon, PA, United States
Additional offices
San Diego, CA, United States · Methuen, MA, United States · Memphis, TN, United States · Seven Hills, Australia · Barueri, Brazil · Bremen, Germany · Kowloon Bay, Hong Kong · Milan, Italy · Tokyo, Japan · Brunssum, Netherlands · Amstelveen, Netherlands · Singapore · Johannesburg, South Africa · Risch Rotkreuz, Switzerland · Northampton, United Kingdom · San Antonio, TX, United States · Limerick, PA, United States · Columbia, MD, United States · West Carrollton, OH, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Globus Medical?
Investment decisions at Globus Medical are made by its executive leadership and board of directors, not by a single family office or founding family. The CEO as of 2025 is Dan Scavilla, who leads strategy alongside the executive team. The company is publicly traded on the NYSE (GMED) and subject to shareholder oversight.
How does Globus Medical source proprietary technology?
Globus Medical operates an internal rapid design-prototype-test cycle using its own fabrication and testing facilities in Pennsylvania. The product development teams work directly from surgeon feedback to identify unmet clinical needs. This vertical integration allows the firm to control intellectual property and manufacturing in-house rather than relying on external contract manufacturers.
Is Globus Medical structured as a family office?
No, Globus Medical is a publicly traded corporation (NYSE: GMED). It does not operate as a family office or asset manager. The firm functions as a medical device manufacturer with a market capitalization of roughly $8B as of early 2025.
What investment stages does Globus Medical target?
Globus Medical does not make external investments; it allocates capital internally toward R&D, manufacturing capacity, and strategic acquisitions. The firm executed a major acquisition of NuVasive in 2024 for $3.1B. Acquisitions serve to expand its product portfolio across spine, orthopedic, and enabling technologies.
Which sectors does Globus Medical focus on?
Globus Medical focuses exclusively on musculoskeletal technology, including spinal implants and instruments, orthopedic trauma and joint reconstruction products, regenerative biologics, and surgical robotics and navigation systems (Excelsius platform). The firm explicitly avoids unrelated industries.
Where does the underlying wealth come from?
Globus Medical is a public company and does not generate wealth for a single family. Its revenue comes from sales of medical devices and surgical technologies to hospitals and healthcare providers globally. The firm reported $2.5B in revenue in 2024 (per SEC filing).
Does Globus Medical maintain philanthropic structures?
Globus Medical operates the Musculoskeletal Education and Research Center (MERC) which provides surgeon education and supports clinical research. MERC partners with surgeon faculty to offer cadaveric labs, didactic sessions, and peer-to-peer training programs. The firm does not disclose a separate charitable foundation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: